Cytokinetics, Incorporated
IT ˙ BIT ˙ US23282W6057
62,32 € 0,00 (0,00%)
2026-06-03
DEL PRIS
SecurityIT:1CYTK / Cytokinetics, Incorporated
InstitutionAlgert Global Llc
Latest Disclosed Ownership117,120 shares
Latest Disclosed Value $ 7,719
Algert Global Llc reports 128.26% increase in ownership of 1CYTK / Cytokinetics, Incorporated

On May 14, 2026 - Algert Global Llc filed a 13F-HR form disclosing ownership of 117,120 shares of Cytokinetics, Incorporated (IT:1CYTK) valued at $6,324,480 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 51,310 shares of Cytokinetics, Incorporated. This represents a change in shares of 128.26% during the quarter. The current value of the position is $7,298,918 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CYTOKINETICS COM NEW 23282W605 117,120 65,810 128.26 8 133.33 0.1161
2026-02-17 2025-12-31 13F CYTOKINETICS COM NEW 23282W605 51,310 -1,150 -2.19 3 50.00 0.0508
2025-11-14 2025-09-30 13F CYTOKINETICS COM NEW 23282W605 52,460 -7,930 -13.13 3 100.00 0.0482
2025-08-14 2025-06-30 13F YTOKINETICS COM NEW 23282W605 60,390 -55,930 -48.08 2 -75.00 0.0418
2025-05-13 2025-03-31 13F CYTOKINETICS COM NEW 23282W605 116,320 57,640 98.23 5 100.00 0.1156
2025-02-14 2024-12-31 13F CYTOKINETICS COM NEW 23282W605 58,680 10,010 20.57 3 0.00 0.0649
2024-11-12 2024-09-30 13F CYTOKINETICS COM NEW 23282W605 48,670 -22,738 -31.84 3 -33.33 0.0691
2024-08-15 2024-06-30 13F CYTOKINETICS COM NEW 23282W605 71,408 27,738 63.52 4 0.00 0.1287
2024-05-15 2024-03-31 13F CYTOKINETICS COM NEW 23282W605 43,670 -150 -0.34 3 0.00 0.1198
2024-02-14 2023-12-31 13F CYTOKINETICS COM NEW 23282W605 43,820 28,370 183.62 4 0.1473
2023-11-13 2023-09-30 13F CYTOKINETICS COM NEW 23282W605 15,450 15,450 0 0.0214
2023-05-12 2023-03-31 13F CYTOKINETICS COM NEW 23282W605 0 -39,143 -100.00 0 -100.00
2023-02-14 2022-12-31 13F CYTOKINETICS COM NEW 23282W605 39,143 0 0.00 2 -99.95 0.0994
2022-11-15 2022-09-30 13F CYTOKINETICS COM NEW 23282W605 39,143 5,917 17.81 1,896 45.29 0.1146
2022-08-15 2022-06-30 13F CYTOKINETICS COM NEW 23282W605 33,226 358 1.09 1,305 7.85 0.0981
2022-05-16 2022-03-31 13F CYTOKINETICS COM NEW 23282W605 32,868 27,948 568.05 1,210 440.18 0.0792
2022-02-14 2021-12-31 13F CYTOKINETICS COM NEW 23282W605 4,920 4,920 224 0.0280
2021-05-14 2021-03-31 13F CYTOKINETICS COM NEW 23282W605 0 -36,684 -100.00 0 -100.00
2021-02-12 2020-12-31 13F CYTOKINETICS COM NEW 23282W605 36,684 36,684 762 0.2173
2020-02-18 2019-12-31 13F CYTOKINETICS COM NEW 23282W605 0 -14,388 -100.00 0 -100.00
2019-11-13 2019-09-30 13F CYTOKINETICS COM NEW 23282W605 14,388 14,388 164 0.0611
2016-05-10 2016-03-31 13F CYTOKINETICS COM NEW 23282W605 0 0 0 0.0000
2016-02-12 2015-12-31 13F CYTOKINETICS COM NEW 23282W605 0 -73,181 -100.00 0 -100.00
2015-10-28 2015-09-30 13F CYTOKINETICS COM NEW 23282W605 73,181 0 0.00 490 -0.41 0.2717
2015-08-24 2015-06-30 13F CYTOKINETICS COM NEW 23282W605 73,181 0 0.00 492 -0.81 0.2713
2015-05-12 2015-03-31 13F CYTOKINETICS COM NEW 23282W605 73,181 -4,669 -6.00 496 -20.51 0.2752
2015-02-11 2014-12-31 13F CYTOKINETICS COM NEW 23282W605 77,850 48,910 169.00 624 511.76 0.3696
2014-11-10 2014-09-30 13F CYTOKINETICS COM NEW 23282W605 28,940 9,190 46.53 102 8.51 0.0756
2014-08-11 2014-06-30 13F CYTOKINETICS COM NEW 23282W605 19,750 19,750 94 0.0606
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.